Form 4 for TELA TELA Bio, Inc.
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001062993-22-005779 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-25 | 2022-02-23 | TELA | Greenhalgh Ellis Skott | CTO | A - Grant | $0.00 | +3,900 | 28.8K | +16% | $0 |
| D | 2022-02-25 | 2022-02-23 | TELA | Greenhalgh Ellis Skott | CTO | A - Grant | $0.00 | +6,675 | 6,675 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | A | A | 3,900 | $0.00 | 28,799 | D | — | — | (F1) These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-23 | A | A | 6,675 | $0.00 | 6,675 | D | $11.75 · — to 2032-02-23 | 6,675 Common Stock | (F2) The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. |